Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice.
about
Rotavirus vaccines in routine useThe impact of new vaccine introduction on immunization and health systems: a review of the published literatureRotavirus vaccines: current status and future considerationsHospitalizations for intussusception before and after the reintroduction of rotavirus vaccine in the United States.The control of rotavirus gastroenteritis in the United StatesLaboratory-Confirmed Rotavirus Disease in Utah Children: Clinical and Economic Impact of Rotavirus Vaccination.Examining the use of ICD-9 diagnosis codes for primary immune deficiency diseases in New York State.Efficacy and safety of pentavalent rotavirus vaccine in Japan: a randomized, double-blind, placebo-controlled, multicenter trial.Impact of rotavirus vaccines on rotavirus disease.Effectiveness and impact of rotavirus vaccines in the United States - 2006-2012.Effectiveness of vaccination with the pentavalent rotavirus vaccine in Nicaragua as determined using the screening method.Norovirus as the cause of medically attended gastroenteritis: a hospital-based experience.Treatment and prevention of rotavirus infection in children.Acute gastroenteritis hospitalizations among children aged < 5 years before and after introduction of rotavirus vaccines: a hospital-based surveillance study in Galicia, Spain.Rotavirus vaccines: safety, efficacy and public health impact.Rotavirus virus-like particles (RV-VLPs) vaccines: An update.Indirect Rotavirus Vaccine Effectiveness for the Prevention of Rotavirus Hospitalization: A Systematic Review and Meta-Analysis.Adoption of rotavirus vaccine by U.S. physicians: progress and challenges.Hospitalization of the elderly in the United States for nonspecific gastrointestinal diseases: a search for etiological clues
P2860
Q26853690-E083AFA5-D35E-4015-A699-88457628566AQ27009450-64D3BE90-4470-4D91-B3EB-DCB3213E66ECQ27021385-7E6A5A95-4ED8-4CCB-9F1C-0C2FE2BA6ACAQ36235204-D77D3BA8-121B-4AF2-8D89-5B99DE2DCBEAQ36519692-AA0B05B3-CCF7-43D7-BDBD-537E31FE323EQ36851125-A2943470-6745-4A43-8DD7-AF6CA171BA2FQ36949421-0EFDE2E7-E7D9-47E7-B19A-F5B44A2B6909Q37530043-091C76B5-A43A-4B7D-8232-6FDBFC8C1787Q38018979-92758CBC-2036-4471-81A7-80BFC638C18FQ38176032-60CBF1E2-E304-48C3-99FF-9E96FCCC53D7Q38409090-02C7004B-8B7A-4FFB-952C-01463A68461BQ40754450-3E734CF2-8B51-4D7C-8CBC-F9AA524094CCQ42269528-E2CB2D92-E164-4FBD-8073-8C5A3750F525Q44179589-2B2D6CD1-9456-478F-8BC6-A703BAAD9BD2Q45165657-850CA0CC-7C6F-4EAD-BADC-397E08FC1393Q45326050-ADF402C1-BB78-4EBB-B164-6476794147A1Q50048817-DCBB1BB7-F661-4B28-9190-AE237ED477FAQ55381145-DA96BD3D-E823-44A7-97C2-810FF097E613Q58112044-0E847FF7-74B5-44DA-9D8E-A7B0C5965F32
P2860
Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Reduction in gastroenteritis w ...... vaccine in a primary practice.
@en
Reduction in gastroenteritis w ...... vaccine in a primary practice.
@nl
type
label
Reduction in gastroenteritis w ...... vaccine in a primary practice.
@en
Reduction in gastroenteritis w ...... vaccine in a primary practice.
@nl
prefLabel
Reduction in gastroenteritis w ...... vaccine in a primary practice.
@en
Reduction in gastroenteritis w ...... vaccine in a primary practice.
@nl
P356
P1433
P1476
Reduction in gastroenteritis w ...... vaccine in a primary practice.
@en
P2093
Keith Perrin
Rodolfo E Bégué
P356
10.1542/PEDS.2009-2069
P407
P577
2010-06-29T00:00:00Z